Table 2 Clinicopathological characteristics after surgery (n = 13)
Surgical procedure | |
Lobectomy | 8 |
Lobectomy with partial resection of another lobe | 2 |
Lobectomy with partial resection of diaphragm | 1 |
Lobectomy with reconstruction of pulmonary artery | 1 |
Extirpation of abdominal lymph node | 1 |
Ef | |
Ef.0 | 2 |
Ef.1 | 2 |
Ef.2 | 5 |
Ef.3 (pathological complete response, pCR) | 4 |
yp-stage | |
yp-stage 0 (pCR) | 4 |
yp-stage IA2 | 2 |
yp-stage IA3 | 1 |
yp-stage IIB | 2 |
yp-stage IIIA | 2 |
yp-stage IVA | 2 |
Surgery time (minutes) | 242.1 (139–446) |
Intraoperative blood loss (g) | 415.1 (25–2660) |
Postoperative complications (grade) | Total number |
Atelectasis (grade 1) | 1 |
Atelectasis (grade 2) | 2 |
Respiratory failure (grade 3) | 1 |
Respiratory failure (grade 4) | 2 |
Hemorrhage of gastric ulcer (grade 5) | 1 |
Drainage period (median, days) | 3.0 (2–9) |
Postoperative hospital stay (median, days) | 8.0 (7–150) |
Total hospital stay (median, days) | 12.0 (8–154) |
Postoperative follow-up period (mean, months) | 25.4 (2–51) |
Total follow-up period (mean, months) | 35.8 (9–63) |
Postoperative chemotherapy | |
Pemetrexed and pembrolizumab | 2 |
Nivolumab and ipilimumab | 1 |
Atezolizumab | 1 |
None | 9 |
Recurrence | 3 |
Death | 3 |